These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 90168)

  • 1. Phosphonoformate inhibition of visna virus replication.
    Sundquist B; Larner E
    J Virol; 1979 Jun; 30(3):847-51. PubMed ID: 90168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphonoformate inhibits reverse transcriptase.
    Sundquist B; Oberg B
    J Gen Virol; 1979 Nov; 45(2):273-81. PubMed ID: 94344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visna virus as an in vitro model for human immunodeficiency virus and inhibition by ribavirin, phosphonoformate, and 2',3'-dideoxynucleosides.
    Frank KB; McKernan PA; Smith RA; Smee DF
    Antimicrob Agents Chemother; 1987 Sep; 31(9):1369-74. PubMed ID: 2445282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of visna virus replication and cytopathic effect in sheep choroid plexus cell cultures by selected anti-HIV agents.
    Thormar H; Balzarini J; Debyser Z; Witvrouw M; Desmyter J; De Clercq E
    Antiviral Res; 1995 May; 27(1-2):49-57. PubMed ID: 7486958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of visna virus replication by 2',3'-dideoxynucleosides and acyclic nucleoside phosphonate analogs.
    Thormar H; Balzarini J; Holy A; Jindrich J; Rosenberg I; Debyser Z; Desmyter J; De Clercq E
    Antimicrob Agents Chemother; 1993 Dec; 37(12):2540-4. PubMed ID: 7509142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of cytomegalovirus late antigens by phosphonoformate.
    Wahren B; Oberg B
    Intervirology; 1980; 12(6):335-9. PubMed ID: 6244238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiviral effects of phosphonoformate (PFA, foscarnet sodium).
    Oberg B
    Pharmacol Ther; 1982; 19(3):387-415. PubMed ID: 6201932
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of human T-cell lymphotropic virus type III in vitro by phosphonoformate.
    Sandstrom EG; Kaplan JC; Byington RE; Hirsch MS
    Lancet; 1985 Jun; 1(8444):1480-2. PubMed ID: 2409414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of recombinant human alpha A interferon on Visna virus multiplication in acutely infected ovine cells.
    Canivet M; Hurpin C; Rozain F; Tanaka A; Lasneret J; Debons-Guillemin MC; Périès J
    J Biol Regul Homeost Agents; 1989; 3(3):122-7. PubMed ID: 2560315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of human immunodeficiency virus reverse transcriptase by 2',3'-dideoxynucleoside triphosphates: template dependence, and combination with phosphonoformate.
    Starnes MC; Cheng YC
    Virus Genes; 1989 May; 2(3):241-51. PubMed ID: 2474897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effects of foscarnet on herpesvirus multiplication in cell culture.
    Schnürer J; Oberg B
    Arch Virol; 1981; 68(3-4):203-9. PubMed ID: 6268019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of hepatitis-B-virus DNA polymerase by phosphonoformate: studies on its mode of action.
    Hess G; Arnold W; Meyer zum Büschenfelde KH
    J Med Virol; 1980; 5(4):309-16. PubMed ID: 6453206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversible inhibition of cytomegalovirus replication by phosphonoformate.
    Wahren B; Oberg B
    Intervirology; 1980; 14(1):7-15. PubMed ID: 6259084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maedi-visna virus, a model for in vitro testing of potential anti-HIV drugs.
    Salvatori D; Vincenzetti S; Maury G; Gosselin G; Gaubert G; Vita A
    Comp Immunol Microbiol Infect Dis; 2001 Apr; 24(2):113-22. PubMed ID: 11247044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance of visna virus to interferon.
    Carroll D; Ventura P; Haase A; Rinaldo CR; Overall JC; Glasgow LA
    J Infect Dis; 1978 Nov; 138(5):614-7. PubMed ID: 213502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic and therapeutic effects of phosphonoformate against feline leukemia virus in vitro.
    Swenson CL; Polas PJ; Cheney CM; Kociba GJ; Mathes LE
    Am J Vet Res; 1991 Dec; 52(12):2010-5. PubMed ID: 1724122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mode of action of phosphonoformate as an anti-herpes simplex virus agent.
    Cheng YC; Grill S; Derse D; Chen JY; Caradonna SJ; Connor K
    Biochim Biophys Acta; 1981 Jan; 652(1):90-8. PubMed ID: 6260189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential inhibition of DNA polymerase and RNase H activities of the reverse transcriptase by phosphonoformate.
    Margalith M; Falk H; Panet A
    Mol Cell Biochem; 1982 Mar; 43(2):97-103. PubMed ID: 6178013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Marked inhibitory activity of masked aryloxy aminoacyl phosphoramidate derivatives of dideoxynucleoside analogues against visna virus infection.
    Balzarini J; Cahard D; Wedgwood O; Salgado A; Velázquez S; Yarnold CJ; De Clercq E; McGuigan C; Thormar H
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Apr; 17(4):296-302. PubMed ID: 9525429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased efficacy of phosphonoformate and phosphonoacetate inhibition of herpes simplex virus type 2 replication by encapsulation in liposomes.
    Szoka FC; Chu CJ
    Antimicrob Agents Chemother; 1988 Jun; 32(6):858-64. PubMed ID: 2843083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.